Se ti è piaciuto questo articolo:
ISCRIVITI ALLA NEWSLETTER
BIBLIOGRAFIA
Fredrickson, D. S., Levy, R. I., and Lees, R. S., Fat trans.-port in lipoproteins-an integrated approach to mechanisms and disorders. New Engi. J. Med. 276, 32, 94, 148, 215, 273 (1967).
Fredrickson, D. S., and Levy, R. I., Familial hyperlipopro-teinemia. Chap. 28 in The Metabolic Basis of Inherited Disease, 3rd ed., McGraw-Hill, New York, N. Y. 1972, p 531.
Beaumont, J. L., Carlson, L. A., Cooper, G. R., Fejfar, Z., Fredrickson, D. S., and Strasser, T., Classification of hyperlipi-daemias and hyperlypoproteinemias. Bull. WHO 43, 891 (1970).
Hatch, F. T., and Lees, R. S., Practical methods for plasma lipoprotein analysis. Advan. Lipid Res. 6, 1 (1968).
Total cholesterol procedure N-24b. Auto-Analyzer Manual, Technicon Instruments Corp., Tarrytown, N. Y., 1964.
Kessler, G., and Lederer, H., Fluorometric measurement of triglycerides. In Automation in Analytical Chemistry, Technicon Symposic 1965, L. T. Skeggs, Jr., et al., Eds. Mediad, New York, 1966, p 341.
Fredrickson, D. S., Levy, R. I., and Lindgren, F. T., A com-parison of heritable abnormal lipoprotein patterns as defined by two different techniques. J. Clin. Invest. 47, 2446 (1968).
Draper, N. R., and Smith, H., Applied Regression Analysis, John Wiley and Sons, Inc., New York, N. Y., 1966, p 33.
Dixon, W. J., and Massey, F. J., Jr., Introduction to Statistical Analysis, McGraw-Hill, New York, N. Y., 1957, p 127.
Dixon, W. J., and Massey, F. J., Jr., Introduction to Sta-tistical Analysis, McGraw-Hill, New York, N. Y., 1957, p 130.
Draper, N. R., and Smith, H., Applied Regression Analysis, John Wiley and Sons, Inc., New York, N. Y., 1966, p 7.
Quarfordt, S., Levy, R. I., and Fredrickson, D. S., On the lipoprotein abnormality in Type III hyperlipoproteinemia. J. Clin. Invest. 50, 754 (1971).
Rubies-Prat J, Reverter JC, Senti M, Pedro-Botet J, Salinas I, Lucas A, et al. Calculated low-density lipoprotein cholesterol should not be used for management of lipoprotein abnormalities in patients with diabetes mellitus. Diabetes Care 1993;16:1081–6.
Branchi A, Rovellini A, Torri A, Sommariva D. Accuracy of calcu-lated serum low-density lipoprotein cholesterol for the assessment of coronary heart disease risk in NIDDM patients. Diabetes Care 1998;21:1397–402.
Hirany A, Li D, Jialal I. A more valid measurement of low-density lipoprotein cholesterol in diabetic patients. Am J Med 1997;102:48–53.
Johnson R, McNutt P, MacMahon S, Robson R. Use of the Friede-wald formula to estimate LDL-cholesterol in patients with chronic renal failure on dialysis. Clin Chem 1997;43:2183–4.
Matas C, Cabre M, La Ville E, Prats E, Joven J, Turner PR, et al. Limitations of the Friedewald formula for estimating low-density lipoprotein choleterol in alcoholics with liver disease. Clin Chem 1994;40:404–6.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concen-tration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.
McNamara JR, Leary ET, Ceriotti F, Boersma-Cobbaert CM, Cole TG, Hassemer DJ, et al. Point: status of lipid and lipoprotein stan-dardization. Clin Chem 1997;43:1306–10.
McNamara JR, Cohn JS, Wilson PW, Schaefer EJ. Calculated values for low-density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary disease risk. Clin Chem 1990;36:36–42.
Kuba K, Frantz IDJ. Validity of the Friedewald equation for the estimation of plasma low-density lipoprotein cholesterol Abstract. Clin Chem 1987;33:896.
Wilson PWF, Zech LA, Gregg RE, et al. Estimation of VLDL cholesterol in hyoperlipidemia. Clin Chim Acta 1985;151:285–91.
Wilson PW, Abbott RD, Garrison RJ, Castelli WP. Estimation of very-low-density lipoprotein cholesterol from data on triglyceride concentration in plasma. Clin Chem 1981;27:2008–10.
DeLong DM, DeLong ER, Wood PD, Lippel K, Rifkind BM. A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol: the Lipid Research Clinics prev-alence study. J Am Med Assoc 1986;256:2372–7.
Lane DM. Calculated low-density lipoprotein cholesterol level: time for a change. The Am J Cardiol 1997;80:823.
Scharnagl H, Nauck M, Wieland H, Marz W. The Friedewald formula underestimates LDL cholesterol at low concentrations. Clin Chem Lab Med 2001;39:426–31.
Adult Treatment Panel III. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. J Am Med Assoc 2001;285:2486–97.
Durrington PN. Can measurement of apolipoprotein B replace the lipid profile in the follow-up of patients with lipoprotein disorders? Clin Chem 2002;48:401–2.
Connelly PW, Poapst M, Davignon J, Lussier-Cacan S, Reeder B, Lessard R, et al. Reference values of plasma apolipoproteins A-I and B, and association with nonlipid risk factors in the populations of two Canadian provinces: Quebec and Saskatchewan. Canadian Heart Health Surveys Research Group. Can J Cardiol 1999;15:409–18.
Contois JH, McNamara JR, Lammi-Keefe CJ, Wilson PW, Massov T, Schaefer EJ. Reference intervals for plasma apolipoprotein B deter-mined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clin Chem 1996;42:515–23.
Sniderman AD, St-Pierre A, Cantin B, Dagenais GR, Depres J-P, Lamarche B. Concordance/discordance between plasma apoB100 levels and the cholesterol indices of vascular risk. Am J Cardiol 2003;91:1173–77.
Sniderman AD, Furberg CD, Keech A, Roeters, van Lennep JE, Frohlich J, Jungner I, Walldius G. Apolipoproteins versus lipids as indices of coronary risk and as targets for statin therapy treatment. Lancet 2003;361:777–80.
Miller WG, Waymack PP, Anderson PA, Ethridge SF, Jayne EC. Performance of four homogeneous direct methods for LDL-choles-terol. Clin Chem 2002;48:489–98.
Nauck M, Warnick GR, Rifai N. Methods for measurement of LDL-cholesterol: A critical assessment of direct measurement by homoge-neous assays versus calcultion. Clin Chem 2002;48:236–54.
Usui S, Kakuuchi H, Okamoto M, Mizukami Y, Okazaki M. Differ-ential reactivity of two homogeneous LDL-cholesterol methods to LDL and VLDL subfractions, as demonstrated by ultracentrifugation and HPLC. Clin Chem 2002;48:1946–54.
Heart Protection Study Collaborative Group. MRC/BHF Heart Pro-tection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7–22.
Sniderman AD, Scantlebury T, Cianflone K. Hypertriglyceridemic hyperapoB: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus. Ann Intern Med 2001;135:447–59.
Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 2001;358:2026–33.
Talmud PJ, Hawe E, Miller GJ, Humphries SE. Non-fasting apoli-poprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men. Arterioscler Thromb Vasc Biol 2002;22:1918–23.
Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Despres JP. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 1997;95:69–75.
Naito HK. The cholesterol challenge: from laboratory to clinician. Clin Chem. 1988;34:444–449.
The Expert Panel. Summary of the Second Report of the National Cholesterol Education Panel (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015–3023.
Fisher M, Levine PH, Weiner BH. Atherosclerosis and the benefits of omega-3 fatty acids. Lab Manage. 1987;25:26–31.
Eaton SB, Konner M. Paleolithic nutrition: a consideration of its nature and current implications. N Engl J Med. 1985;312:283.
Wang TY, Chen RM, Teng Leary E. Accuracy of serum lipid measurements in Taiwan using fresh human serum in a survey. J Biomed Lab Sci. 1996;8:129–134.
Grundy SM. The role of therapy with statins in patients with hypertriglyc-eridemia. Am J Cardiol. 1998;81(4A):1B–6B.
Schaefer EJ. New recommendations for the diagnosis and treatment of blood cholesterol abnormalities. AACC Lipids and Lipoproteins Division News Letter. 1993;11(2):5–12.
Leino A, Impivaara O, Kaitsaari M, Járvisalo J. Serum concentrations of apo-lipoprotein A-1, apolipoprotein B, and lipoprotein (a) in a population sample. Clin Chem. 1995;41:1633–1636.
Friedman RB, Young DS, eds. Effects of Diseases on Clinical Laboratory Tests. 3rd ed. Washington, DC: AACC Press; 1997:3468–3469.
Gouache P, Le Moullac B, Bleiberg-Daniel F, Aubert R, Flament C. Chang-es in rat plasma apolipoproteins and lipoproteins during moderate protein defi-ciency: potential use in the assessment of nutritional status. J Nutr. 1991;121:653–662.
Jacobs DR Jr, Barrett-Conmor E. Retest reliability of plasma cholesterol and triglyceride: The Lipid Research Clinics Prevalence Study. Am J Epidemiol. 1982;116:878–885.
Nakamura Y, Motokawa M. Hypolipemia associated with the wasting con-dition of rabbits infected with strongyloides papillosus. Vet Parasitol. 2000;88:147–151.
Wang X, Wang W, Bengmark S, Andersson R. Alterations of lipid contents in blood, hepatocytes, and enterocytes in the early stage of acute liver failure induced by 90% hepatectomy in the rat. J Surg Res. 1995;59:326–336.
Miller GJ, Miller NE. Plasma high-density-lipoprotein concentration and development of ischaemic heart disease. Lancet 1975;1:16–19.
Carlson LA, Bottiger LE, Ahfeldt PE. Risk factors for myocardial infarction in the Stockholm prospective study: a 14-year follow-up focusing on the role of plasma triglycerides and cholesterol. Acta Med Scand 1979;206:351–360.
Castelli WP, Garrison RJ, Wilson PWF, Abbott RO, Kalonsdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cho-lesterol levels: the Framingham Study. JAMA 1986;256:2385–2387.
Hokanson JE, Austin MA. Plasma triglyceride level in a risk factor for cardiovascular disease independent of high-density lipoprotein choles-terol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996;3:213–219.
Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WS, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988;260:1917–1921.
Reaven GM, Chen YD-I, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest 1993;92:141–146.
Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study. Arterioscler Thromb Vasc Biol 1997;1114–1120.
Gaziano JM, Hennekens CH, O’Donnell CJ, Breslow JL, Buring JE. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation 1997;96:2520–2525.
Pei D, Jones CNO, Bhargava R, Chen Y-DI, Reaven GM. Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test. Diabetologia 1994;37:843–845.
Shen, S-W, Reaven GM, Farquhar JW. Comparison of impedance to insulin-mediated glucose uptake in normal and diabetic subjects. J Clin Invest 1970;49:2151–2160.
Greenfield MS, Doberne L, Kraemer FB, Tobey TA, Reaven GM. Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes 1981;30:387–392.
Yeni-Komshian H, Carantoni M, Abbasi F, Reaven GM. Relationship between several surrogate estimates of insulin resistance and quanti-fication of insulin-mediated glucose disposal in 490 healthy, nondia-betic volunteers. Diabetes Care 2000;23:171–175.
Hales CN, Randle PJ. Immunoassay of insulin with insulin-antibody precipitate. Biochem J 1963;88:137–146.
Cheal KL, Abbasi F, Lamendola C, McLaughlin T, Reaven GM, Ford ES. Relationship to insulin resistance of the Adult Treatment Panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes 2004;53:1195–1200.
Olefsky JM, Farquhar JW, Reaven GM. Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med 1974;57:551–560.
Laws A, Reaven GM. Evidence for an independent relationship be-tween insulin resistance and fasting plasma HDL-cholesterol, triglyc-eride and insulin concentrations. J Int Med 1992;231:25–30.
Krauss RM, and Dreon DM. Low-density-lipoprotein subclasses and response to a low-fat diet in healthy men. Am J Clin Nutr 1995;62:478S–487S.
Dreon DM, Fernstrom HA, Williams PT, Krauss RM. Reduced LDL particle size in children consuming a very-low-fat diet is related to parental LDL-subclass patterns. Am J Clin Nutr 2000;71:1611–1616.
Dreon DM, Fernstrom HA, Williams PT, Krauss RM. LDL subclass patterns and lipoprotein response to a low-fat, high-carbohydrate diet in women. Arterioscler Thromb Vasc Biol 1997;17:707–714.
Woodward M. Epidemiology Study Design and Data Analysis. Boca Raton, Florida: Chapman & Hall/CRC Press, 1999.
NCEP Expert Panel. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2002;285:2846–2897.
Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 1992;137:959–965.
Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595–1607.
Reaven GM. The insulin resistance syndrome. Curr Atheroscler Rep 2003;5:364–371.
Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem 2001;34:583–588.
Yip J, Facchini FS, Reaven GM. Resistance to insulin-mediated glu-cose disposal as a predictor of cardiovascular disease. J Clin Endocri-nol Metab 1998;83:2773–2776.
Facchini FS, Hua N, Abbasi F, Reaven GM. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 2001;86:3574–3578.
COLESTEROLO LDL Determinazione diretta – https://www.centralino.it/sanitario/enciclopedia medica/Prestazione/66986060f346c4608ef269b0/COLESTEROLO-LDL-Determinazione-diretta.
Colesterolo HDL – LDL, Buono e Cattivo – Auxologico, accesso eseguito il giorno luglio 15, 2025, https://www.auxologico.it/colesterolo.
Colesterolo totale, LDL e HDL: facciamo chiarezza – Enfea Salute, accesso eseguito il giorno luglio 15, 2025, https://www.enfeasalute.it/colesterolo-totale-ldl-hdl/.
Colesterolo HDL e LDL: quali sono le differenze e come ridurre quello cattivo, accesso eseguito il giorno luglio 15, 2025, https://www.poliambulatoriomodoetia.it/salute/colesterolo-hdl-e-ldl-quali-sono-le-differenze-e-come-ridurre-quello-cattivo/.
Colesterolo e ipercolesterolemia – Epicentro.Iss.it, accesso eseguito il giorno luglio 15, 2025, https://www.epicentro.iss.it/colesterolo/.
Colesterolo LDL – Labtestsonline, accesso eseguito il giorno luglio 15, 2025, https://labtestsonline.it/lto-tests/colesterolo-ldl.html.
Colesterolo LDL, cosa ci dicono le ultime linee guida. – SIPREC, accesso eseguito il giorno luglio 15, 2025, https://www.siprec.it/pubblicazioni/articoli-scientifici/siprec/colesterolo-ldl-ultime-linee-guida.html.
Colesterolo: significato, funzioni e valori da tenere d’occhio – Micuro, accesso eseguito il giorno luglio 15, 2025, https://www.micuro.it/enciclopedia/prestazioni/colesterolo-esami-sangue-metabolismo.
Linee guida per la prevenzione dell’aterosclerosi – Ministero della …, accesso eseguito il giorno luglio 15, 2025, https://www.salute.gov.it/imgs/C_17_pubblicazioni_1097_allegato.pdf.
Test del Colesterolo LDL diretto – Labtestsonline, accesso eseguito il giorno luglio 15, 2025, https://labtestsonline.it/lto-tests/test-del-colesterolo-ldl-diretto.html.
Colesterolo Ldl, ecco cos’è il colesterolo “cattivo” – Santagostino Magazine, accesso eseguito il giorno luglio 15, 2025, https://www.santagostino.it/magazine/colesterolo-ldl/.
Calcolo del colesterolo LDL (formula di Friedwald) – Medincò, accesso eseguito il giorno luglio 15, 2025, https://www.medinco.it/portale/app/Calcolo-colesterolo-LDL.htm.
Quantificazione delle lipoproteine aterogeniche per le terapie ipolipemizzanti: Raccomandazioni di Consenso della European Atherosclerosis Society (EAS) e di EFLM – Biochimica Clinica, accesso eseguito il giorno luglio 15, 2025, https://biochimicaclinica.it/wp-content/uploads/2023/02/1634-2020.078_Traduzione_EFLM4.pdf.
Calcolo del Colesterolo LDL con la formula di Friedewald – SISMED, accesso eseguito il giorno luglio 15, 2025, https://www.sismed-it.com/calcolo-colesterolo-ldl-formula-friedewald-tecniche-enzimatiche/.
Linee Guida per la Diagnostica di Laboratorio delle Dislipidemie – SIBioC, accesso eseguito il giorno luglio 15, 2025, https://sibioc.it/wp-content/uploads/2021/04/4Dlq7G.pdf.
valori colesterolo: livelli ottimali e quando fare le analisi, accesso eseguito il giorno luglio 15, 2025, https://www.keepitpumping.com/it-it/colesterolo/valori-analisi.
www.keepitpumping.com, https://www.keepitpumping.com/it-it/colesterolo/valori-analisi#:~:text=La%20quantit%C3%A0%20di%20colesterolo%20LDL,%2D%20(trigliceridemia%2F5).
FORMULA DI FRIEDEWALD – Dizionario medico – Dica33, accesso eseguito il giorno luglio 15, 2025, https://www.dica33.it/dizionario-medico/24899/formula-di-friedewald.asp.
Come misurare il colesterolo delle LDL? – – SISMED, accesso eseguito il giorno luglio 15, 2025, https://www.sismed-it.com/misurare-il-colesterolo-ldl/.
Correlation Analysis of Direct LDL Measurement and Calculated LDL Methods in Lipid Profile Assessment: A Comprehensive Study, accesso eseguito il giorno luglio 15, 2025, https://ifccfiles.com/2025/01/eJIFCC2024vol35No4pp244-264.pdf.
COLESTEROLO LDL (CALCOLO INDIRETTO) Sigla test: LDL Codice SISS: 009013B Metodo analitico – puntiraf.it, accesso eseguito il giorno luglio 15, 2025, https://www.puntiraf.it/wp-content/uploads/2023/07/COLESTEROLO-LDL-calcolo-indiretto.pdf.
COLESTEROLO LDL: l’importanza del dosaggio diretto – Poliambulatorio Exacta Srl, accesso eseguito il giorno luglio 15, 2025, https://www.poliambulatorioexacta.it/colesterolo-ldl/.
Colesterolo alto: quando preoccuparsi e come mangiare – Starbene, accesso eseguito il giorno luglio 15, 2025, https://www.starbene.it/salute/problemi-soluzioni/colesterolo-alto-quando-preoccuparsi-come-mangiare/.
Friedewald-Estimated Versus Directly Measured Low-Density Lipoprotein Cholesterol and Treatment Implications | JACC, https://www.jacc.org/doi/10.1016/j.jacc.2013.01.079.
Understanding Strengths and Limitations of Different Methods of LDL-C Estimation, https://www.acc.org/Latest-in-Cardiology/Articles/2019/04/02/13/21/Understanding-Strengths-and-Limitations-of-Different-Methods-of-LDL-C-Estimation.
Calcolo Colesterolo LDL – medicidiercolano, https://www.medicidiercolano.it/old/1/Colesterolo.php.
LDL Calculated – MDCalc, https://www.mdcalc.com/calc/70/ldl-calculated.
Directly Measured vs. Calculated Low-Density Lipoprotein Cholesterol Does Not Identify Additional Individuals With Coronary Artery Disease and Diabetes at Higher Risk of Adverse Events: Insight From a Large Percutaneous Coronary Intervention Cohort in Asia – Frontiers, https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.932878/full.
Comparison of Estimated LDL Cholesterol Equations with Direct Measurement in Patients with Angiographically Confirmed Coronary Artery Disease – MDPI, accesso eseguito il giorno luglio 15, 2025, https://www.mdpi.com/2308-3425/9/10/342.
LDL-Colesterolo, accesso eseguito il giorno luglio 15, 2025, https://www.sbt.ti.ch/all/vetrina/20291.pdf.
Colesterolo LDL – Metodo Enzimatico Colorimetrico – Istruzione per l’uso (IFU) – sclavo.diagnostics, accesso eseguito il giorno luglio 15, 2025, https://www.sclavodiagnostics.com/wp-content/uploads/2022/11/IFU-COLESTEROLO-LDL-IT.pdf.
Misurazione diretta del colesterolo-LDL e sue possibili conseguenze sulla terapia farmacologica – La Rivista Italiana della Medicina di Laboratorio 2023 Dicembre;19(4):266-72 – Minerva Medica, accesso eseguito il giorno luglio 15, 2025, https://www.minervamedica.it/it/riviste/medicina-laboratorio/articolo.php?cod=R54Y2023N04A0266.
Colesterolo, un killer sottovalutato. Come ridurre il rischio cardiovascolare – insalutenews.it, accesso eseguito il giorno luglio 15, 2025, https://www.insalutenews.it/in-salute/colesterolo-un-killer-sottovalutato-come-ridurre-il-rischio-cardiovascolare/.
Colesterolo Ldl: nuovi limiti per prevenire le malattie cardiovascolari, accesso eseguito il giorno luglio 15, 2025, https://www.fondazioneveronesi.it/magazine/cardiologia/colesterolo-ldl-i-nuovi-limiti-per-prevenire-le-malattie-cardiovascolari.
Colesterolo Ldl, ecco cos’è il colesterolo “cattivo” – Santagostino, accesso eseguito il giorno luglio 15, 2025, https://www.santagostino.it/it/santagostinopedia/colesterolo-ldl.
Colesterolo Ldl cosa è, costi e prenotazioni – CupSolidale, accesso eseguito il giorno luglio 15, 2025, https://www.cupsolidale.it/prestazione/58cfe56143d05/.
Società Italiana per lo Studio dell’Aterosclerosi – Ipercolesterolemia familiare: le nuove linee guida europee – SISA, accesso eseguito il giorno luglio 15, 2025, http://www.sisa.it/index.php?class=Comp&className=Content&op=Show¶m=cid,12 60,preview,0.
Linee guida ESC 2021 per la prevenzione delle malattie cardiovascolari nella pratica clinica elaborate dalla Task Force per la prevenzione delle malattie cardiovascolari nella pratica clinica costituita da rappresentanti della Società Europea di Cardiologia e di 12 società medico-scientifiche con il contributo straordinario dell’Associazione Europea di Cardiologia Preventiva (EAPC) | Giornale Italiano di Cardiologia – Organo ufficiale, accesso eseguito il giorno luglio 15, 2025, https://www.giornaledicardiologia.it/archivio/3808/articoli/37926/.
CLASSIFICAZIONE DEL RISCHIO CARDIOVASCOLARE E OBIETTIVI TERAPEUTICI ALLA LUCE DELLE RECENTI LINEE GUIDA ESC/EAS – SISA, accesso eseguito il giorno luglio 15, 2025, http://www.sisa.it/upload/GIA_2020_n2_3.pdf.
ESC Guidelines on Dyslipidaemias (Management of) – European Society of Cardiology, accesso eseguito il giorno luglio 15, 2025, https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Dyslipidaemias-Management-of.
II Consensus Conference Italiana sulla LDL-aferesi – SISA, accesso eseguito il giorno luglio 15, 2025, http://www.sisa.it/upload/II_CCI_LDL_aferesi.pdf.
DOCUMENTO DI CONSENSO SULLA LIPOPROTEINA(A) DELLA SOCIETÀ ITALIANA PER LO STUDIO DELL’ATEROSCLEROSI (SISA), accesso eseguito il giorno luglio 15, 2025, http://www.sisa.it/upload/GIA_2023_n3_2.pdf.
Colesterolo Totale – Labtestsonline, accesso eseguito il giorno luglio 15, 2025, https://labtestsonline.it/lto-tests/colesterolo-totale.html.
Colesterolo e trigliceridi alti: le nuove linee guida europee diventano ancor più aggressive e se le medicine sono tante un promemoria può aiutare – Network Bibliotecario Sanitario Toscano, accesso eseguito il giorno luglio 15, 2025, https://www.nbst.it/537-colesterolo-ldl-trigliceridi-alti-dislipidemia-linee-guida-2019.html.
Colesterolo LDL – In cosa consiste l’esame e quali sono i valori corretti?, accesso eseguito il giorno luglio 15, 2025, https://www.materdomini.it/visite-ed-esami/colesterolo-ldl/.
Test del profilo lipidico: scopo, risultati, intervallo normale e altro – Apollo Hospitals, accesso eseguito il giorno luglio 15, 2025, https://www.apollohospitals.com/it/diagnostics-investigations/lipid-profile-test.
colesterolo ldl alto: implicazioni cliniche ed approcci nutrizionali – Nutrizionista Bergamo – Dott. Francesco Pepino, Biologo, accesso eseguito il giorno luglio 15, 2025, https://pepinonutrizionista.it/colesterolo-ldl-alto-implicazioni-cliniche-ed-approcci-nutrizionali/.
Endowiki: Metodologia e laboratorio.
https://www.poliambulatorioexacta.it/colesterolo-ldl/.
https://www.puntiraf.it/wp-content/uploads/2023/07/COLESTEROLO-LDL-calcolo-indiretto.pdf.
https://www.sbt.ti.ch/all/vetrina/20291.pdf.
https://labtestsonline.it/lto-tests/test-del-colesterolo-ldl-diretto.html.
https://labtestsonline.it/lto-tests/colesterolo-ldl.html.
https://elty.it/guide/tipologie-di-colesterolo.
https://www.farmaciaeuropea.it/Blog/13856/Qual-e-il-rapporto-tra-colesterolo-LDL-e-HDL-e-come-si-calcola.html.
https://www.auxologico.it/colesterolo.
https://biochimicaclinica.it/wp-content/uploads/2023/02/1634-2020.078_Traduzione_EFLM4.pdf.
https://www.santagostino.it/magazine/colesterolo-ldl/.
https://www.sismed-it.com/misurare-il-colesterolo-ldl/.
https://biochimicaclinica.it/metodi-indiretti-per-la-determinazione-e-la-verifica-degli-intervalli-di-riferimento/.
https://www.mollie.com/it/growth/direct-vs-indirect-cash-flow.
https://www.salvatidiagnostica.it/tampone-faringeo-rapido-o-colturale/.
https://simedet.eu/wp-content/uploads/2021/07/Il-laboratorio-e-le-tecniche-diagnostiche.pdf.
https://centrodiagnosticoippocrate.it/blog/durata-richiesta-analisi-del-sangue/.
http://www.medicalsystems.it/wp-content/uploads/1998/06/109_Controllo-Gestione.pdf.
https://www.ladiagnostica.it/tecnologia-avanzata.html.
https://www.connectendress.it/fotometria-e-fotometri.
https://www.futurlab.it/pillola-formativa-chimica-liquida-vs-chimica-secca/.
https://it.monadlabtech.com/blogs/how-does-high-performance-liquid-chromatography-hplc-achieve-compound-separation.
https://it.wikipedia.org/wiki/Cromatografia_liquida_ad_alta_prestazione.
https://www.waters.com/nextgen/it/it/education/primers/beginner-s-guide-to-liquid-chromatography/how-does-high-performance-liquid-chromatography-work.html.
https://moodle2.units.it/pluginfile.php/362861/mod_resource/content/1/cromatografie_teoria classica e cinetica intro GC.pdf.
https://moodle2.units.it/pluginfile.php/433761/mod_resource/content/1/14_ cromatografie_teoria classica e cinetica 20211108.pdf.
https://www.agilent.com/Library/usermanuals/Public/G4220-94301_1290InfinityLC-System_IT.pdf.
https://it.monadlabtech.com/blogs/how-to-elute-a-peak-in-hplc.
https://www.waters.com/nextgen/it/it/education/primers/preparative-liquid-chromatography-primer/scouting-gradients.html.
https://www.sigmaaldrich.com/IT/it/technical-documents/technical-article/analytical-chemistry/small-molecule-hplc/hplc-troubleshooting-guide.
https://www.paramedical.it/wp-content/uploads/2018/01/PDI101880.pdf.
https://pmc.ncbi.nlm.nih.gov/articles/PMC4687457/.
https://pubmed.ncbi.nlm.nih.gov/8361044/.
https://pubmed.ncbi.nlm.nih.gov/7503661/.
https://pubmed.ncbi.nlm.nih.gov/7611188/.
https://academic.oup.com/labmed/article-pdf/27/9/613/24955864/labmed27-0613.pdf.
https://www.dstunisannio.it/sites/default/files/2019-11/8.Tecniche immunologiche.pdf.
https://www.docenti.unina.it/webdocenti-be/allegati/materiale-didattico/34070488.
https://biologipugliabasilicata.it/wp-content/uploads/2023/07/Tecniche-immunochimiche.pdf.
https://www.unife.it/scienze/chimica/insegnamenti/chimica-bioanalitica/analisi-immunochimica.
https://elearning.unite.it/mod/resource/view.php?id=77260.
https://www.treccani.it/enciclopedia/immunologia_(Enciclopedia-Italiana)/.
https://it.pearson.com/content/dam/region-core/italy/pearson-italy/pdf/diritto-economia/esame-stato/esame-stato-2013/AREE DISCIPLINARI – PARAMOND – ESAME – 2013 – PDF – Prova Alimenti alimentazione IPSAR.pdf.
https://lnx.centrostudihelios.it/wp-content/uploads/2016/01/L22.pdf.
https://it.wikipedia.org/wiki/Trasformazione_agroalimentare.
https://publ.iss.it/ITA/Items/GetPDF?uuid=21419a21-07c2-451b-bf2b-12d34aa15ff8.
https://www.endowiki.it/index.php/news/73-contenuti/laboratorio.
AVVERTENZE
Le informazioni contenute in questo sito sono solo a scopo didattico. Questo sito non fornisce e non può fornire consulenza medica. Non deve essere usato come sostituto delle cure mediche e dei consigli del tuo medico. Potrebbero esserci variazioni sul trattamento che il medico può raccomandare in base a fatti e circostanze individuali. La medicina è una scienza dinamica e dovrebbe essere considerata di conseguenza. Queste informazioni non devono essere utilizzate per diagnosticare o trattare alcuna condizione. Non siamo responsabili per il modo in cui utilizzi e implementi le informazioni che ricevi. Questo sito è destinato all’uso solo da parte di adulti sani. Il Sito non è destinato all’uso da parte di minori, donne in gravidanza o individui con qualsiasi tipo di condizione di salute.
NON IGNORARE MAI I CONSIGLI MEDICI PROFESSIONALI A CAUSA DI QUALCOSA CHE HAI LETTO SU QUESTO SITO. NON AFFIDARTI MAI ALLE INFORMAZIONI CHE HAI RICEVUTO SU QUESTO SITO INVECE DI CERCARE UNA CONSULENZA MEDICA PROFESSIONALE. CONTATTA SEMPRE IL TUO MEDICO DI FIDUCIA E CHIEDI IL SUO PARERE SULLE INFORMAZIONI CHE LEGGI SU QUESTO SITO. LEGGI SU QUESTO SITO SENZA IL PARERE DEL TUO MEDICO DI FIDUCIA. NON UTILIZZARE QUESTO SITO PER LE EMERGENZE MEDICHE.
